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Abstract
Introduction: Gestational choriocarcinoma occurs in 1 in 40,000 pregnancies. Of all forms of
gestational choriocarcinoma, placental choriocarcinoma is the most rare. Maternal
choriocarcinoma is usually diagnosed in symptomatic patients with metastases. The incidental
finding of a choriocarcinoma confined to the placenta with no evidence of dissemination to the
mother, or infant is the least common scenario.
Case presentation: The patient is an 18 year-old Gravida 1 Para 1 African American female who
delivered a viable 3641 g female infant at 39 weeks gestation. Her pregnancy course was
complicated by gestational hypertension during the third trimester. Her placenta revealed
intraplacental choriocarcinoma. She was then followed closely by the Gynecologic Oncology
service with a weekly serum beta human chorionic gonadotropin value. Beta human chorionic
gonadotropin values dropped from 3070 mIU/ml to less than 2 mIU/ml two months post partum.
No chemotherapy was initiated. Metastasis was ruled out by chest x-ray and whole body computed
tomography scan. To date, both mother and baby are well.
Conclusion: Due to the potential fatal outcome of placental choriocarcinoma, careful evaluation
of both mother and infant after the diagnosis is made is important. The incidence of placental
choriocarcinoma may actually be higher than expected since it is not routine practice to send
placentas for pathological evaluation after a normal spontaneous delivery. The obstetrician,
pathologist, and pediatrician should have an increased awareness of placental choriocarcinoma and
its manifestations.
Introduction
Gestational choriocarcinoma occurs in 1 in 40,000 preg-
nancies. It is a highly aggressive malignant tumor of the
trophoblasts found in association with any form of gesta-
tion. Of all forms of gestational choriocarcinoma, placen-
tal choriocarcinoma is the most rare and is usually
diagnosed in symptomatic patients with metastases.
Metastases to the lung and brain usually occur in the
mother, but metastatic choriocarcinoma in the fetus or
neonates does occur. The incidental finding of a chorio-
carcinoma confined to the placenta with no evidence of
dissemination to mother or infant is the least common
scenario.
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The patient is an 18 year-old African American Gravida 1
Para 0 at her 39th weeks of gestation who presented to a
hospital in the St. Louis area in early labor. After rupture
of membranes, light meconium was noted. The patient
subsequently delivered a viable female infant vaginally,
weighing 3641 g, with Apgar scores of 9 and 9 at 1 and 5
minutes. Her pregnancy course was complicated by gesta-
tional hypertension during the third trimester. She was
treated with magnesium sulfate during labor for possible
pre-eclampsia due to elevated blood pressure intrapar-
tum. Her blood pressure was normal after delivery, and
her post partum course was unremarkable. The placenta
appeared to be grossly normal with a 3 vessel cord at the
time of delivery. Because of the patient's history of gesta-
tional hypertension, the placenta was sent to pathology
and placental choriocarcinoma was diagnosed (Figures 1
&2). She was then referred to and followed closely by the
Gynecologic Oncology service. Her serum beta human
chorionic gonadotropin (hCG) dropped from 3070 mIU/
ml to less than 2 mIU/ml six weeks post partum. No
chemotherapy was initiated. She had also undergone mul-
tiple studies such as chest x-ray and computed tomogra-
phy (CT) scan which all ruled out metastasis during the
one year post partum period. The infant was followed by
the pediatric service. To date, both mother and baby have
been disease free for eight years.
Pathologic findings
The placenta measured 15 × 16 × up to 4 cm with a
trimmed weight of 530 grams and was notable only for a
3 cm cyst-like area on cut section. Microscopic examina-
tion showed a choriocarcinoma with a biphasic prolifera-
tion of atypical and mitotically active cytotrophoblast and
syncytiotrophoblast notable for extensive involvement of
villi, many completely encompassed by collars of neo-
plastic trophoblast. Some villi were partially involved
with a transition from normal to neoplastic trophoblast.
There was no involvement of villous stromal vessels. The
tumor showed extensive central necrosis in which the
ghost-like outlines of necrotic villi could be discerned.
The remainder of the placenta was mature, showing only
focal villous edema.
Discussion
We performed a medline search (1966 to 2008) using the
keywords placenta, choriocarcinoma, and trophoblastic dis-
ease. We found 21 articles with 32 cases of placental chor-
iocarcinoma in the English literature. Fourteen cases of
choriocarcinoma were confined to the placenta with no
evidence of dissemination to mother or infant; five of
these 14 cases were incidentally identified in patients with
normal pregnancies. To our knowledge, our case is the
sixth of this type.
Choriocarcinoma in the placenta differs somewhat from
those occurring elsewhere. The majority of placental cho-
riocarcinomas appeared as poorly defined lesions macro-
scopically, and they are often interpreted as placental
infarcts or intervillus thrombi. It is often only after meta-
static symptoms occur in mother or infant that the pla-
centa is resubmitted for further evaluation, and small
lesions are identified microscopically. When recognized
grossly, most placental choriocarcinomas have been
described as yellow-white granular lesions thought to be
infarcts. Microscopically, placental choriocarcinomas usu-
ally revealed areas in which the trophoblast is distributed
as a mantle around villi with partial involvement and
transition from normal trophoblast. This surface villous
Interface between choriocarcinoma with central necrosis (top) nd normal placenta (hematoxilin and eosin staining)Figure 1
Interface between choriocarcinoma with central 
necrosis (top) and normal placenta (hematoxilin and 
eosin staining).
Villi surrounded by collars of neoplastic trophoblast (arrows)F gure 2
Villi surrounded by collars of neoplastic trophoblast 
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posed of necrotic, confluent trophoblast and villi explain-
ing its gross resemblance to an infarct. Invasion of villous
stroma has been described in rare cases.
Obstetrically, the majority of the reported cases had a nor-
mal prenatal course. Placental choriocarcinoma was often
diagnosed after the mother developed symptoms of
metastasis either antepartum or postpartum. The symp-
toms included vaginal bleeding, chest pain, and neurolog-
ical signs such as seizures and stroke. In terms of maternal
outcome, mothers who developed metastasis were often
treated with chemotherapy which consisted of etoposide,
methotrexate, actinomycin-D, cytoxan or vincristine. The
response rate after chemotherapy is high; the majority of
mothers were disease free after 1 year. Four mothers died
of disease, but these 4 cases all occurred in the early 1980s
[1,2]. Kodama et al reported a case where the mother
underwent partial lobectomy after pulmonary lesions
were identified in 1994 [3]. Four cases of hysterectomy
were reported by Brewer et al in 1981, Ollendorf in 1990,
and Flam in 1996 [1,4,5]. In mothers with no evidence of
metastasis, only three of the 14 cases were treated with
chemotherapy; the others were followed with serial serum
hCG measurement until it dropped to zero during the
post partum course. Multiple imaging modalities such as
X-ray, CT scan and magnetic resonance imaging were
often used to rule out metastasis. Our patient continued
to have annual follow-up with the Gynecologic Oncology
service after multiple studies to rule out metastasis in the
first year post partum.
In terms of fetal outcome, ten cases resulted in either
intrauterine demise or neonatal death. In 2006, Liu and
Guo reported the only case in which an infant was suc-
cessfully treated with chemotherapy after metastasis to
jejunum and lungs was identified [6]. Most of the infants
born showed no evidence of disease after 1 year.
Due to the potential fatal outcome of placental choriocar-
cinoma, the diagnosis should require careful evaluation of
both mother and infant. Other clinical manifestations
such as hyperthyroidism which is sometimes associated
with high serum HCG should also be ruled out. Hyperem-
esis gravidarum is a common symptom in patients with
hyperthyroidism. Serial serum beta hCGs and imaging
studies should be employed to rule out metastasis. Mater-
nal metastasis is very responsive to chemotherapy. Fetal
metastasis is rare and usually fatal. In cases where placen-
tal choriocarcinoma is confined to the placenta without
evidence of metastasis, only three of the 14 cases were
treated with methotrexate chemotherapy, and the others
were followed by serial beta hCG and imaging studies, all
with excellent outcome. We believe in these cases, no
chemotherapy is needed, providing serial beta hCG and
imaging studies during postpartum follow up remain nor-
mal.
Conclusion
It is not a routine practice to send a placenta for patholog-
ical evaluation following a normal spontaneous delivery.
However, a number of cases, like ours, reported incidental
findings of placental choriocarcinoma in asymptomatic
mothers and infants with no evidence of metastases. In
the majority of these cases, the placenta was sent to
pathology due to other pregnancy complications such as
intrauterine growth restriction, pre-eclampsia, maternal
fetal hemorrhage, and in our case, gestational hyperten-
sion. It is our belief that the incidence of placental chori-
ocarcinoma may actually be higher than reported. It is
also well established that early detection and treatment of
gestational trophoblastic disease improves treatment out-
come. The obstetrician, pathologist and pediatrician
should have an increased awareness of placental chorio-
carcinoma and its manifestations. Clinical suspicion and
any gross placental anomaly should mandate a thorough
pathological examination of the placenta.
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